You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 8, August 2007 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Radiation Therapy
 •Neoplasms of Head & Neck
 •Dentistry/ Oral Medicine
 •Alert me on articles by topic

Sentinel Node Biopsy in N0 Squamous Cell Carcinoma of the Oral Cavity and Oropharynx in Patients Previously Treated With Surgery or Radiation Therapy

A Pilot Study

Robert D. Hart, MD; Eric Henry, MD; Joseph G. Nasser, MD; Jonathan R. Trites, MD; S. Mark Taylor, MD; Martin Bullock, MD; David Barnes, MD

Arch Otolaryngol Head Neck Surg. 2007;133(8):806-809.

Objectives  To assess the feasibility of sentinel lymph node (SLN) localization and to determine the predictive value of SLN biopsy for occult neck metastases in patients previously treated with surgery or radiation therapy and with N0 squamous cell carcinoma of the oral cavity or oropharynx.

Design  Prospective case series.

Setting  Tertiary academic hospital.

Patients  Eleven patients with T1 to T4 N0 squamous cell carcinoma of the oral cavity or oropharynx.

Interventions  Patients underwent preoperative peritumoral injection of technetium Tc 99m sulfur colloid followed by dynamic lymphoscintigraphy and operative localization of the SLN(s) with the use of a handheld gamma probe.

Main Outcome Measures  The presence or absence of metastatic disease in N0 squamous cell carcinoma of the oral cavity and oropharynx in patients previously treated with surgery or radiation therapy as identified by SLN biopsy findings.

Results  In each of the 11 patients, 1 to 3 SLNs were identified by lymphoscintigraphy. All SLNs identified by lymphoscintigraphy were successfully identified and removed with the use of an intraoperative gamma probe. In 10 of the 11 patients, the biopsy findings from the SLN(s) accurately predicted the presence or absence of occult neck metastasis. There was 1 instance of a negative SLN with a positive neck dissection. The overall negative predictive value of the study was 91%. No aberrant lymphatic drainage patterns were observed in this study.

Conclusion  In patients previously treated with surgery or radiation therapy, SLN biopsy was as effective as in previously untreated patients according to published reports and warrants inclusion of this patient group into larger studies.


Author Affiliations: Division of Otolaryngology–Head and Neck Surgery (Drs Hart, Henry, Nasser, Trites, and Taylor), Department of Pathology (Dr Bullock), and Division of Nuclear Medicine (Dr Barnes), Dalhousie University, Halifax, Nova Scotia, Canada.







HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2007 American Medical Association. All Rights Reserved.